XPeng: Competing Well, Hold For Now — Positive

XPEV   Seeking Alpha — May 23, 2025

XPeng's 2025 China sales surged to 72% of Tesla's, up from 17% last year, showcasing rapid market share gains. Strong Mona M03 model sales and growing exports signal XPeng's increasing global competitiveness. XPeng's tech edge, including high XNGP adoption and new ADAS insurance, boosts its valuation potential.

image for news XPeng: Competing Well, Hold For Now

Transaction in Own Shares — Neutral

DEC   GlobeNewsWire — May 23, 2025

DIVERSIFIED ENERGY COMPANY PLC ("Diversified", or the "Company") DIVERSIFIED ENERGY COMPANY PLC (LSE:DEC, NYSE:DEC) announces that, in accordance with the terms of its share buyback programme announced on 20 March 2025, the Company has purchased 18,718 Ordinary Shares of 20 Pence each in the capital of the Company (the "Shares") in the market at a volume-weighted average price of $13.6938 per Share through Mizuho Securities USA LLC (MSUSA). The Shares acquired will, in due course, be cancelled.

image for news Transaction in Own Shares

Nu Holdings: A Top Fintech Play For 2025 — Positive

NU   Seeking Alpha — May 23, 2025

Nu Holdings delivered strong Q1 results last week, maintaining rapid customer growth and improving monetization, especially in core markets like Brazil. The fintech added 19M new customers in the last year, reaching 119M total customers by the end of Q1. Deposits in Brazil are surging, and so are the fintechs' overall gross profits.

image for news Nu Holdings: A Top Fintech Play For 2025

Pricing of Senior Secured Notes — Neutral

FLUT   GlobeNewsWire — May 23, 2025

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO

image for news Pricing of Senior Secured Notes

Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the results of the votes of its Combined Shareholders' Meeting.

image for news Results of the Votes of the Combined Shareholders' General Meeting of May 22, 2025

Mastercard: The Long-Term Compounding Train Marches On — Positive

MA   Seeking Alpha — May 23, 2025

Mastercard continues to deliver mid-teens growth and strong margins, defying concerns about competition and market saturation. Both Mastercard and Visa are essential long-term holdings, with underestimated dominance and significant growth potential, especially in value-added services. Visa is closing the growth gap with Mastercard, but both trade at reasonable valuations given their superior quality and growth outlook.

image for news Mastercard: The Long-Term Compounding Train Marches On

Apple is offering additional trade-in discounts for new iPhones in China until June 18, according to its website on Friday.

image for news Apple offers additional trade-in discounts for new iPhones in China

Kayne Anderson BDC: Q1 Earnings Weaken Appeal (Rating Downgrade) — Negative

KBDC   Seeking Alpha — May 23, 2025

Kayne Anderson remains attractively valued in a premium BDC sector, but recent earnings and weaker distribution coverage warrant caution. Net investment income has declined, and dividend coverage is now tight, raising the risk of a potential cut if conditions don't improve. Portfolio fundamentals are strong with diversified, first-lien, floating-rate debt, but rising non-accruals and high rates present headwinds.

image for news Kayne Anderson BDC: Q1 Earnings Weaken Appeal (Rating Downgrade)

Regulated Information Nyrstar NV releases notice for the 2024 annual general shareholders' meeting to be held on 24 June 2025 23 May 2025 at 07.00 CEST Nyrstar NV (the “Company”) today issued the notice for the 2024 annual general shareholders' meeting to be held on 24 June 2025 at 11:00 a.m. CEST. The annual general meeting will be held physically with no virtual option available.

image for news Nyrstar NV releases notice for the 2024 annual general shareholders' meeting to be held on 24 June 2025

Outcome of Innate Pharma's 2025 Annual General Meeting — Neutral

IPHA   Business Wire — May 23, 2025

MARSEILLE, France--(BUSINESS WIRE)-- #AG--Outcome of Innate Pharma's 2025 Annual General Meeting.

image for news Outcome of Innate Pharma's 2025 Annual General Meeting

MARSEILLE, France--(BUSINESS WIRE)-- #immunotherapy--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the presentation of long-term follow-up data from the Phase 2 TELLOMAK clinical trial evaluating lacutamab, an anti-KIR3DL2 monoclonal antibody, in patients with Sézary syndrome (SS) and mycosis fungoides (MF), two rare and aggressive forms of cutaneous T-cell lymphoma (CTCL). The results will be presented at the American Society of Clinical Oncol.

image for news Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=149874&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Canopy Growth Corporation (CGC) Shareholders of Class Action Lawsuit and June 3, 2025 Deadline

Is Brookfield Infrastructure's ~6% Dividend Safe? — Positive

BIP   Seeking Alpha — May 23, 2025

Brookfield Infrastructure offers stable, inflation-protected returns from a diverse portfolio of physical assets, making it attractive in today's volatile market environment. BIP's affiliation with Brookfield enhances deal flow and financing, boosting efficiency and shareholder value. Despite seemingly high payout ratios, the Company's cash flows comfortably cover its nearly 6% dividend, which we view as safe and set to grow.

image for news Is Brookfield Infrastructure's ~6% Dividend Safe?

Oil Prices Slump as OPEC+ Weighs Another Major Supply Hike — Negative

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   Bloomberg Markets and Finance — May 23, 2025

Oil headed for its first weekly decline in three, as OPEC+ members discussed another major production increase. Bloomberg's Nicholas Lua breaks down the situation.

image for news Oil Prices Slump as OPEC+ Weighs Another Major Supply Hike

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=149873&wire=1&utm_campaign=2 or contact Joseph E.

image for news Securities Lawsuit Alert: Bitfarms Ltd. (BITF) Investors - Contact Levi & Korsinsky Before July 8, 2025

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149871&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

image for news Investors in Avis Budget Group, Inc. (CAR): Protect Your Rights - Contact Levi & Korsinsky Before June 24, 2025

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149872&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

image for news May 27, 2025 Deadline: Join Class Action Lawsuit Against Actinium Pharmaceuticals, Inc. (ATNM) - Contact Levi & Korsinsky

Lazard: Emerging markets outside China will benefit from trade tensions — Positive

LAZ   CNBC International TV — May 23, 2025

Ron Temple of Lazard says the U.S. stock market looks 'unreasonably optimistic', and that emerging markets will benefit from trade tensions as companies de-risk their supply chains. He also believes the U.S.-China trade tensions are far from over.

image for news Lazard: Emerging markets outside China will benefit from trade tensions

I rate Celsius a sell/avoid due to weak profitability, scoring only 40/100 in my quantitative system. The Company's high SGA expenses, especially marketing, and low net profit margin (8.4%) highlight its lack of a clear market advantage. Despite impressive historical EPS growth, recent earnings volatility and declining growth rates make CELH's future performance unpredictable and risky.

image for news Celsius: Avoid Investing Despite The Impressive Earnings Growth And Price Decline

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=149868&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Civitas Resources, Inc. (CIVI) Shareholders of Class Action Lawsuit and July 1, 2025 Deadline